26 May 2026

strategyland.uk

Croda International PLC (CRDA)

Rank #42 of 100 - Basic Materials - UK Equities

Home/Stocks/Basic Materials

Croda International PLC

CRDA.L·Basic Materials·Market Cap £3.9b

Rank #42 of 100

Data from Excel Model · 100 Stocks Analysed

£28.32

+4.90% YTD

Target: £34.10(+20.4%)

52W: £24.27 - £33.12

Score Analysis

Croda International PLC is ranked #42 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

58/100

Average Score

Liquidity

Excellent12/100

Valuation

Weak83/100

Profitability

Fair57/100

Solvency

Excellent19/100

Asset Efficiency

Weak95/100

Mkt Trading

Weak85/100

Technical

Fair56/100

1. Valuation

Score: 83/100

Is CRDA undervalued compared to its peers and fair value metrics?

1/5

valuation criteria met

✗

FY26e P/E Ratio

17.8xRank 72/100

✗

FY27e P/E Ratio

15.8xRank 73/100

✓

Price-to-Book

1.72xRank 35/100

✗

Price-to-Tangible Book

4.17xRank 43/100

✗

EV/EBITDA

10.8xRank 54/100

Key Valuation Metrics

Current P/E

63.7x

Price-to-Earnings

FY26e P/E

17.8x

Forward estimate

FY27e P/E

15.8x

Forward estimate

P/B Ratio

1.72x

Price-to-Book

P/TBV

4.17x

Price-to-Tangible Book

EV/EBITDA

10.8x

Enterprise Value

FY26e EV/EBITDA

10.0x

Forward estimate

FY27e EV/EBITDA

10.0x

Forward estimate

Analyst Consensus Target

Current Price

£28.32

Consensus Target

£34.10

Potential

+20.4%

Target

Bloomberg Median Target: £33.75

2. Profitability

Score: 57/100

How profitable is CRDA relative to its peers?

1/6

profitability criteria met

✓

TTM Profit Margin

3.8%Rank 19/100

–

Current ROE

2.8%

–

Current ROA

N/A

✗

FY26e EPS

1.78Rank 60/100

–

TTM EPS

1.65

–

Net Income Growth

N/A

Profit Margin

3.8%

ROE

2.8%

FY27e ROE

10.8%

ROA

N/A

Earnings Per Share

3. Financial Health

Score: 19/100

How strong is CRDA's balance sheet and financial position?

0/4

solvency criteria met

–

Debt-to-Equity

31.6%

–

Interest Coverage

N/A

✗

Debt/EBITDA

Rank 62Rank 62/100

–

Altman Z-Score

3.34

Key Health Metrics

Quick Ratio

1.18

Healthy

Cash Ratio

1.99

Debt/Equity

32%

FCF Margin

1.2%

Altman Z-Score

3.34

Safe Zone

01.812.995+

4. Asset Efficiency

Score: 95/100

How efficiently does CRDA deploy its assets and intellectual capital?

1/2

asset efficiency criteria met

–

Intangible/Asset

Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations

N/A

✓

R&D/Sales

Research & development spend relative to revenue — balanced R&D investment signals sustainable growth

Rank 8/100

Overall Asset Efficiency Rank

Rank within sector peers#95/100

Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.